<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1008820.ref014">
 <label>14</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Gao</surname>
   <given-names>Q</given-names>
  </name>, 
  <name>
   <surname>Bao</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Mao</surname>
   <given-names>H</given-names>
  </name>, 
  <name>
   <surname>Wang</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Xu</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>Yang</surname>
   <given-names>M</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Development of an inactivated vaccine candidate for SARS-CoV-2</article-title>. 
  <source>Science</source>. 
  <year>2020</year>;
  <volume>369</volume>(
  <issue>6499</issue>):
  <fpage>77</fpage>â€“
  <lpage>81</lpage>. Epub 2020/05/08. 
  <pub-id pub-id-type="doi">10.1126/science.abc1932</pub-id>
  <?supplied-pmid 32376603?>
  <pub-id pub-id-type="pmid">32376603</pub-id>
 </mixed-citation>
</ref>
